BMRA - Biomerica, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
5/30/2018
5/30/2017
5/30/2016
Total Revenue
5,201
5,564
5,792
5,140
Cost of Revenue
3,909
3,810
3,770
3,616
Gross Profit
1,292
1,754
2,022
1,524
Operating Expenses
Research Development
1,679
1,398
1,131
780
Selling General and Administrative
2,026
1,838
1,846
1,571
Total Operating Expenses
3,705
3,236
2,976
2,351
Operating Income or Loss
-2,413
-1,482
-955
-827
Interest Expense
0
0
0
0
Total Other Income/Expenses Net
44
48
46
31
Income Before Tax
-2,369
-1,434
-909
-796
Income Tax Expense
24
32
0
704
Income from Continuing Operations
-2,393
-1,466
-909
-1,500
Net Income
-2,393
-1,466
-909
-1,500
Net Income available to common shareholders
-2,393
-1,466
-909
-1,500
Reported EPS
Basic
-
-0.17
-0.11
-0.20
Diluted
-
-0.17
-0.11
-0.20
Weighted average shares outstanding
Basic
-
8,570
8,330
7,626
Diluted
-
8,570
8,330
7,626
EBITDA
-
-1,247
-689
-563